In line with ACR recommendations, allopurinol is strongly proposed as a primary-line urate-reducing medication. Genetic tests is usually recommended (for the variant identified as HLA B*5801) before beginning allopurinol because the carriers of this gene are at a heightened chance of the extreme allergic reaction.Penyelidikan lanjutan sangat berkem